Pneumonia: Symptoms, Diagnosis, 2025–2026 Antibiotic Guidelines and Recovery

Evidence reviewed: 8 November 2026. Pneumonia is an infection of the lung tissue that can cause fever, cough, breathlessness, chest pain and impaired oxygen exchange. It may result from bacteria, viruses and less commonly fungi. Severity ranges from mild illness treated at home to respiratory failure or sepsis requiring hospitalization. The American Thoracic Society (ATS) clinical practice guideline issued in 2025 and published in 2026 updated guidance on lung ultrasound, antibiotics after a positive viral test, treatment duration and systemic corticosteroids. Patients should seek medical evaluation for concerning symptoms rather than assuming all pneumonia requires the same antibiotic [1–4].

What happens in pneumonia?

In pneumonia, infection and inflammation affect the alveoli and surrounding lung tissue, allowing inflammatory fluid and cells to accumulate and interfering with gas exchange. This may cause rapid breathing, shortness of breath, low blood oxygen and cough. Pneumonia is a clinical and radiologic syndrome, not one organism; choosing treatment requires considering where infection began, illness severity, age, immune status and the likely pathogen [1,2].

Community-acquired versus hospital-acquired pneumonia

Type Usual setting Key management implications
Community-acquired pneumonia (CAP) Develops outside hospital or early after admission. Use CAP-specific severity assessment and local empirical therapy guidance.
Hospital-acquired pneumonia (HAP) Develops at least 48 hours after hospital admission and was not incubating at admission. Consider hospital flora, prior antibiotics and resistant organisms.
Ventilator-associated pneumonia (VAP) Develops after at least 48 hours of mechanical ventilation. Requires ICU-specific diagnosis and antimicrobial strategies.
Aspiration-related lung injury May follow aspiration of gastric or oropharyngeal contents. Distinguish chemical pneumonitis from secondary bacterial pneumonia.

This article mainly addresses CAP in immunocompetent adults. Children, pregnancy, significant immunosuppression, ventilator-associated infection and complicated aspiration cases need different clinical pathways. Pneumonia can be life-threatening even when the patient initially appears mildly unwell [1–3].

What causes pneumonia?

Common causes include Streptococcus pneumoniae, other bacterial respiratory pathogens, and viruses such as influenza, SARS-CoV-2 and RSV. Some cases involve atypical bacteria, including Mycoplasma pneumoniae or Legionella species. A bacterial infection may coexist with or follow a viral illness. The exact mix depends on season, geography, age, vaccination and exposures [1,2].

Not every patient with a positive respiratory virus test has exclusively viral pneumonia. Conversely, a radiologic infiltrate does not prove bacteria are responsible. Diagnostic assessment must integrate the clinical course, underlying conditions, imaging and microbiologic findings [1].

Common pneumonia symptoms

  • Cough, sometimes with sputum but occasionally dry.
  • Fever or chills, although older or immunocompromised people may have little fever.
  • Fast or difficult breathing, sometimes with reduced oxygen saturation.
  • Chest pain with deep breathing or coughing (pleuritic pain).
  • Fatigue, muscle aches, poor appetite or general weakness.
  • In older adults, new confusion, falls or functional decline may be prominent.

Green or yellow sputum does not by itself prove bacterial pneumonia; color can reflect inflammatory cells during viral illness too. A cough can also arise from asthma, heart failure, pulmonary embolism or bronchitis, and these alternative diagnoses must be considered.

When is pneumonia an emergency?

Emergency warning signs include severe breathlessness, blue/gray discoloration of lips or skin, new confusion, fainting, persistent chest pain, inability to speak normally because of breathing difficulty, very low oxygen saturation or signs of sepsis. Call local emergency services or seek emergency care. People with high-risk conditions or rapidly worsening symptoms should not wait for a routine clinic visit [2,3].

Children with chest indrawing, lethargy, dehydration or breathing difficulty and infants who cannot feed need urgent medical evaluation. Pregnancy and severe immunosuppression also lower the threshold for assessment.

How is CAP diagnosed?

Diagnosis uses history, examination and chest imaging when appropriate. Chest X-ray may show new pulmonary infiltrates, although early findings can sometimes be subtle. Pulse oximetry helps assess oxygenation. Severe presentations may require blood tests, arterial blood gas, blood cultures, sputum testing or viral molecular assays, depending on setting [1,2].

The 2025 ATS guideline suggests that lung ultrasound can be an acceptable alternative to chest radiography for suspected adult CAP in centers with appropriate clinical expertise. It is not a requirement to use ultrasound for every patient or a claim that an untrained bedside scan can replace all chest imaging [1].

Severity assessment and hospital admission

Clinicians consider respiratory rate, oxygen level, blood pressure, mental status, age, comorbidities and ability to manage at home. Scores such as the Pneumonia Severity Index (PSI) or CURB-65 may support site-of-care decisions but should not override clinical judgment [2].

Factors favoring admission include hypoxemia, hypotension, confusion, inability to tolerate oral treatment, unstable comorbid illness or inadequate support. Severe CAP may require higher-level monitoring, oxygen, intravenous therapy and consideration of ICU criteria.

How are antibiotics chosen for bacterial CAP?

The foundational 2019 ATS/IDSA adult CAP guideline supports narrow, appropriate choices according to comorbidity and resistance risk [2]. For otherwise healthy outpatients with likely bacterial CAP and no relevant resistance risks, initial options include amoxicillin or doxycycline; macrolide monotherapy is appropriate only when local pneumococcal macrolide resistance is under 25% [2].

Adults with significant comorbidities may require amoxicillin/clavulanate or a selected oral cephalosporin plus a macrolide or doxycycline, or a respiratory fluoroquinolone when justified. Fluoroquinolones carry important adverse effects and are not interchangeable with all other antibiotic choices. MRSA or Pseudomonas coverage is not routine for all CAP, but may be necessary with validated resistance risk factors [2].

Patient context Typical guideline approach Important caution
Healthy outpatient, suspected bacterial CAP Amoxicillin or doxycycline; macrolide alone only where local resistance is sufficiently low. Assess allergies, pregnancy, interactions and local epidemiology.
Outpatient with chronic cardiac, lung, liver or renal illness, diabetes or other relevant comorbidity Appropriate combination oral therapy or a carefully selected respiratory fluoroquinolone. Higher bacterial coinfection risk and medication-related harms.
Hospitalized nonsevere CAP Often a beta-lactam plus macrolide or an appropriate alternative regimen. Review local susceptibility, cultures and clinical stability.
Severe CAP Hospital-based regimen, broader assessment and early supportive care. Potential ICU care; organism-specific coverage only when warranted.

These are treatment frameworks, not individual prescriptions. Exact doses and duration depend on kidney/liver function, prior antibiotics, local resistance and whether the infection is uncomplicated.

2025 ATS update: what if respiratory viral testing is positive?

In adults with clinical and imaging evidence of CAP and a positive respiratory virus test, the 2025 ATS guideline conditionally suggests not prescribing empiric antibiotics in otherwise healthy outpatients without comorbidities when bacterial coinfection suspicion is low. The evidence certainty is very low, so shared decision-making and follow-up matter [1].

By contrast, the guideline conditionally suggests empiric antibiotics in outpatients with comorbidities and in hospitalized adults with CAP and a positive virus test, because bacterial coinfection is a concern. Do not interpret a positive flu or COVID test as proof antibiotics are never indicated; the broader clinical picture is essential [1].

How long should antibiotics be taken?

The 2025 ATS guidance suggests less than five days of antibiotics, with a minimum of three days, for selected adult outpatients or hospitalized patients with nonsevere CAP who have achieved clinical stability. This is a conditional recommendation, not a direction to give only three days to every patient [1].

For severe CAP the guideline recommends at least five days rather than a shorter course. Unusual pathogens, complications, empyema, bacteremia, immune compromise and an inadequate response may require a longer or different regimen [1,2].

Clinical situation General ATS duration approach
Nonsevere outpatient CAP with stable clinical response May be under 5 days (minimum 3) under clinician direction [1].
Hospitalized nonsevere CAP that becomes stable May be under 5 days (minimum 3) when all criteria are met [1].
Severe CAP At least 5 days, with duration individualized.
Complicated or resistant infection Often requires specialized treatment, monitoring or extended duration.

Clinical stability includes improvement in vital signs, respiratory and mental status, oral intake and the general disease course. Do not stop antibiotics early without a prescribing clinician’s guidance simply because fever disappeared on the first day.

Do corticosteroids help pneumonia?

The 2025 ATS guideline suggests systemic corticosteroids for selected adults with severe CAP but not for routine nonsevere CAP. The recommendation requires consideration of factors such as influenza-associated pneumonia, hyperglycemia, secondary infection and other risks [1].

Routine steroids are not a home remedy for every cough or infiltrate. COVID-19 treatment recommendations also differ according to oxygen needs; steroids can be harmful in mild infection without an appropriate indication. Corticosteroid treatment should be decided in the clinical context and monitored.

What about oxygen and supportive treatment?

Patients with hypoxemia may need supplemental oxygen and, in severe cases, noninvasive or invasive ventilation. Fluids should support hydration but be adjusted in patients with heart failure or other conditions. Paracetamol/acetaminophen or an appropriate analgesic may ease discomfort, with attention to liver, kidney, gastrointestinal or pregnancy-related restrictions.

Selected patients with influenza pneumonia should receive appropriate antiviral therapy without waiting for a flu test if severe or high risk. COVID-19 antiviral management similarly depends on timing and risk. Neither antiviral therapy nor a positive viral test automatically rules out bacterial coinfection [3,4].

How quickly do symptoms improve?

Some patients begin improving after a few days of effective treatment, but fatigue and cough can persist for weeks. Fever often resolves earlier than full physical endurance returns. Older adults or people hospitalized for severe CAP may need more time, rehabilitation and follow-up [2,3].

Recovery is not identical in every patient. Persistent fatigue alone does not prove antibiotic failure. However, worsening breathing, recurrent fever, chest pain, low oxygen or inability to eat and drink warrants prompt re-evaluation for complications, resistant organisms, another diagnosis or comorbidity.

Practical pneumonia recovery plan

  • Follow the prescribed treatment plan and review timing, side effects and drug interactions.
  • Drink appropriate fluids and maintain adequate food intake, adjusting for fluid restrictions if relevant.
  • Rest during acute illness and return to light activity gradually as breathing and strength improve.
  • Manage fever and discomfort with suitable medicines, avoiding excessive doses or unapproved combinations.
  • Discuss oxygen use, breathing exercises and rehabilitation with the care team when hospitalized or significantly deconditioned.
  • Follow up when advised, especially with smoking history, persistent symptoms, recurrent pneumonia or concern for obstructing disease.

Does everyone need a repeat chest X-ray?

No. Routine repeat imaging is not required for every adult recovering appropriately from uncomplicated CAP. Follow-up imaging may be considered when symptoms fail to improve, there are persistent abnormalities or the person is at elevated risk of underlying malignancy (for example, certain older adults with significant smoking history) [2].

Radiographic resolution can lag behind clinical recovery. A patient can feel better before the original infiltrate fully disappears, so interpreting repeat imaging requires clinical context.

Complications of pneumonia

Possible complications include parapneumonic effusion, empyema, lung abscess, respiratory failure, sepsis and acute worsening of heart or lung conditions. In severe cases, patients may develop acute respiratory distress syndrome (ARDS) or need intensive care.

Failure to improve, recurrent fever, severe pleuritic pain or increasing breathlessness should prompt assessment for complications. A pleural effusion may require ultrasound and, in selected cases, drainage rather than repeated outpatient antibiotics alone.

Preventing pneumonia

Important preventive measures include age- and risk-appropriate pneumococcal vaccination, influenza vaccination, COVID-19 vaccination, smoking cessation, hand hygiene and cleaner indoor air. Older adults or people with certain chronic illnesses may require additional vaccine guidance [3,4].

Vaccines reduce risk but do not prevent every pneumonia case. Good oral health, management of swallowing problems and reducing aspiration risk are important for selected patients; unnecessary prophylactic antibiotics are not routine pneumonia prevention.

Frequently asked questions

Does every pneumonia need an antibiotic?

No. The 2025 ATS guideline suggests some otherwise healthy outpatients with viral-positive CAP may avoid empiric antibiotics when bacterial coinfection suspicion is low [1].

Do all adults need five days of antibiotics?

Not necessarily. Selected clinically stable nonsevere cases may use 3–4 days under the new ATS guidance; severe disease usually needs 5 or more days [1].

Is lung ultrasound acceptable for diagnosing pneumonia?

Yes, where appropriately trained expertise is available, as an alternative to chest radiography for suspected CAP [1].

Should I take corticosteroids for pneumonia at home?

No. Systemic corticosteroids are not routine for nonsevere CAP; selected severe cases may benefit under hospital care [1].

Can pneumonia occur without fever?

Yes. Some older or immunocompromised patients may have low or absent fever.

Can cough persist after infection clears?

Yes. Cough and fatigue may last for weeks, but worsening or recurrent symptoms need reassessment.

Key takeaways

Pneumonia requires severity-based diagnosis and treatment. The 2025 ATS guideline supports expert lung ultrasound, nuanced decisions about antibiotics after viral testing, and shorter courses for clinically stable nonsevere adult CAP. Severe pneumonia and warning signs need urgent care, and recovery may take several weeks even after infection improves.

References

  1. Jones BE, Ramirez JA, Oren E, et al. Diagnosis and management of community-acquired pneumonia: an official American Thoracic Society clinical practice guideline. Am J Respir Crit Care Med. 2026;212(1):24–44. doi:10.1164/rccm.202507-1692ST. Published online July 2025.
  2. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia: ATS/IDSA clinical practice guideline. Am J Respir Crit Care Med. 2019;200:e45–e67. Full guideline.
  3. Centers for Disease Control and Prevention. About pneumonia: causes, symptoms, prevention and care. Accessed 8 Nov 2026.
  4. Centers for Disease Control and Prevention. Preventing respiratory illness. CDC; updated 2026.

Medical disclaimer: Educational information only. Pneumonia antibiotic and steroid decisions require clinical examination, assessment of oxygenation, radiology and local prescribing guidance. Severe breathlessness, confusion, chest pain, cyanosis or signs of sepsis require emergency medical evaluation.

Medical & AI Disclaimer

The information provided on Sumathi Publications is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional regarding any medical condition or treatment decision.

We strive to keep our content accurate and up to date; however, some content may be created or assisted using artificial intelligence (AI) and may contain errors or omissions. All information should be independently verified before use. Reliance on any content provided by Pharmacology Mentor is at your own risk.

Leave a Reply

Your email address will not be published. Required fields are marked *